Clinical trial
Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
NCT03858270 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
- Lead sponsor
- Wayne State University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 1, 2019
- Completion date
- July 1, 2023
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.